Davita Inc vs Sirius XM Holdings Inc — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Sirius XM Holdings Inc trades at $26.52 (market cap $8.87B). The key difference: Davita Inc is the larger of the two by market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Sirius XM Holdings Inc for 102 Days on average.
| DVA | SIRI | |
|---|---|---|
Market Cap | $11.29B | $8.87B |
Volume | 582,204 | 4,324,672 |
Sector | Health | Media |
52-Week High | $240.96 | $32.59 |
52-Week Low | $103.87 | $19.92 |
Typical Hold Time | 113 Days | 102 Days |
Enterprise Value | $24.01B | $18.16B |
Dividend Yield | — | 4.1% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Sirius XM (SIRI) trades at $25.95, down 1.56% with bearish technical signals despite strong analyst support. The company shows mixed earnings performance with Q1 2026 beating expectations but Q2 2026 missing. Fundamentals reveal solid profitability with 10.23% net margin and attractive valuation at P/E of 10.42. Recent developments include a YouTube partnership and strong cash flow growth highlighted in recent conferences.
The stock presents a value opportunity with significant upside to the $34.43 consensus target, though technical weakness and competitive pressures in audio streaming warrant caution. Strong institutional buying and dividend payments provide support, but execution on advertising growth remains critical for sustained appreciation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →